A detailed history of Orser Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Orser Capital Management, LLC holds 2,144 shares of LLY stock, worth $1.95 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares
2,144
Previous 2,154 0.46%
Holding current value
$1.95 Million
Previous $1.95 Million 2.62%
% of portfolio
1.45%
Previous 1.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$772.14 - $960.02 $7,721 - $9,600
-10 Reduced 0.46%
2,144 $1.9 Million
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $5,074 - $6,363
7 Added 0.33%
2,154 $1.95 Million
Q1 2024

Apr 11, 2024

BUY
$592.2 - $792.28 $21,319 - $28,522
36 Added 1.71%
2,147 $1.67 Million
Q4 2023

Jan 09, 2024

SELL
$525.19 - $619.13 $109,764 - $129,398
-209 Reduced 9.01%
2,111 $1.23 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $1.01 Million - $1.39 Million
2,320 New
2,320 $1.25 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Orser Capital Management, LLC Portfolio

Follow Orser Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orser Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orser Capital Management, LLC with notifications on news.